Fujirebio has entered into a long-term license agreement to make the availability of Thermo Fisher Scientific's biomarker assay Procalcitonin (PCT) on its Lumipulse family of laboratory instruments. Under the agreement, Fujirebio will ...
SIRS-Lab has completed enrolling patients in a clinical study of its VYOO molecular diagnostic test, designed to detect presence of pathogens' genetic material from whole blood. The prospective, blinded multicenter study, which has ...
Tags: VYOO molecular diagnostic test, pathogens'genetic material, VYOO test